| 000 | 01520cam a2200445 a 4500 | ||
|---|---|---|---|
| 001 | ocn805010249 | ||
| 003 | AE-DuAU | ||
| 005 | 20241127174034.0 | ||
| 008 | 120726s2012 enka b 001 0 eng | ||
| 015 |
_aGBB274275 _2bnb |
||
| 016 | 7 |
_a101594645 _2DNLM |
|
| 016 | 7 |
_a016135020 _2Uk |
|
| 020 |
_a9780007350742 (pbk.) : _c24.40 |
||
| 020 |
_a0007350740 (pbk.) : _c24.40 |
||
| 035 | _a(OCoLC)805010249 | ||
| 040 | _aBaker & Taylor | ||
| 040 |
_aNLM _beng _cNLM _dUKMGB _dOCLCO _dYDXCP _dEUW _dYNK _dNZWAP |
||
| 042 | _anlmcopyc | ||
| 049 | _aTSAA | ||
| 050 |
_aHD9665.5 _bG65 2012 |
||
| 069 | _a09389898 | ||
| 090 | _aHD 9665.5 G65 2012 | ||
| 100 | 1 |
_aGoldacre, Ben. _9141520 |
|
| 245 | 1 | 0 |
_aBad pharma : _bhow drug companies mislead doctors and harm patients / _cBen Goldacre. |
| 260 |
_aLondon : _bFourth Estate, _c2012. |
||
| 300 |
_axvii, 430 p. : _bill. ; _c22 cm. |
||
| 336 |
_2rdacontent _atext _btxt |
||
| 337 |
_2rdamedia _aunmediated _bn |
||
| 338 |
_2rdacarrier _avolume _bnc |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 650 | 1 | 2 |
_aDrug Industry _xethics. _9141521 |
| 650 | 2 | 2 |
_aClinical Trials as Topic _xethics. _9136454 |
| 650 | 2 | 2 |
_aDrug Evaluation _xethics. _9141522 |
| 650 | 0 |
_aPharmaceutical industry _xCorrupt practices. _927955 |
|
| 852 | 1 | _9P24.20usd | |
| 907 |
_a37753 _b01-06-13 _c01-06-13 |
||
| 942 |
_cBOOK _01 |
||
| 998 |
_aaudmc _b01-06-13 _cm _da _e- _feng _genk _h0 |
||
| 945 |
_g0 _i5081270 _j0 _laudmc _o- _p88.81 _q- _r- _s- _t1 _u1 _v0 _w1 _x0 _yi14901511 _z01-06-13 |
||
| 999 |
_c37753 _d37753 |
||